Impairment of Filgrastim-Induced Stem Cell Mobilization after Prior Lenalidomide in Patients with Multiple Myeloma

Lenalidomide is an agent that has shown great activity in patients with multiple myeloma. However, studies have suggested that this drug negatively affects subsequent stem cell collection. To investigate whether lenalidomide impairs stem cell mobilization and collection, we reviewed data for patient...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biol Blood Marrow Transplant
Main Authors: Popat, Uday, Saliba, Rima, Thandi, Rupinderjit, Hosing, Chitra, Qazilbash, Muzaffar, Anderlini, Paolo, Shpall, Elizabeth, McMannis, John, Körbling, Martin, Alousi, Amin, Andersson, Borje, Nieto, Yago, Kebriaei, Partow, Khouri, Issa, de Lima, Marcos, Weber, Donna, Thomas, Sheeba, Wang, Michael, Jones, Roy, Champlin, Richard, Giralt, Sergio
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4352933/
https://ncbi.nlm.nih.gov/pubmed/19450756
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2009.02.011
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados